FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma By Ogkologos - May 20, 2026 79 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for safety and efficacy is based on the findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR The new home for your research tools April 11, 2022 No Link Between Caffeine Consumption and Breast Cancer, Study Finds September 29, 2021 Jennifer Garner Shared A Video Of Her Mammogram Appointment October 21, 2019 EMA Recommends Granting a Conditional Marketing Authorisation for Selumetinib April 30, 2021 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Lazertinib Bringing a Piece of Home to the Hospital 2-Year-Old Cancer Survivor With Down Syndrome Hears For First Time: ‘Her... ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the...
